JW Shinyak’s third quarter net profit increased by 216% to 6.1 billion won.
(Health Korea News / Chang-yong Lee) JW New Drug announced on the 7th that its net profit in the third quarter (separate basis) achieved KRW 6.1 billion, a 216.9% surge compared to the same quarter last year (KRW 1.9 billion) … Read more